Update on Smoking Product Registration and Renewal: What Companies Need to Know

ANVISA guidelines on registration and renewal of smoking products according to RDC 896/2024

Understand how the update of ANVISA’s guidelines affects the registration and renewal of smoking products and how QR Group can help in the process. ANVISA recently updated its guidelines on the registration and renewal of smoking products derived from tobacco. This change is included in the Collegiate Board Resolution (RDC) 896/2024, which reformulates the requirements […]

ANVISA’s Participation in WHO: Impacts on the Regulation of Medical Products

WHO meeting discusses regulation of counterfeit medical products with participation of ANVISA.

Understand the Importance of ANVISA’s Role in the Global Product Regulation ANVISA is participating in the 13th plenary meeting of the Member States Mechanism on Substandard and Falsified Medical Products (MSMSF) of the World Health Organization (WHO), reinforcing its essential role in product regulation at the international level. The event will take place between November […]

Anvisa Prioritizes Registration of Tests for Arboviruses, Including Dengue and Chikungunya

Diagnostic tests for dengue and other arboviruses being evaluated by scientists.

Anvisa is implementing measures to speed up the registration of diagnostic tests for mosquito-borne diseases, aiming at better control of arboviruses in Brazil. The National Health Surveillance Agency (Anvisa) recently announced that it will prioritize the analysis of requests for registration of tests for the diagnosis of mosquito-borne diseases, such as dengue, chikungunya and oropouche […]

QR Group Explains Data Sharing Agreement Between Anvisa and FDA

Representatives from Anvisa and FDA signing an agreement to exchange data on medicines.

Understand how the new agreement between Anvisa and the FDA can speed up drug approval in Brazil and how QR Group can help your company comply. The National Health Surveillance Agency (Anvisa) and the Food and Drug Administration (FDA), the regulatory body in the United States, have signed an important confidentiality agreement that will facilitate […]

Simplifying the process: regularizing products at ANVISA

Product regularization at ANVISA with support from QR Group.

Understand the essential steps for regularizing products with ANVISA and how QR Group can help your company ensure compliance quickly and safely. If you work in the industry of products that require regularization with the health surveillance agency, you know that regularizing products with ANVISA is a crucial step, not only for marketing, but also […]

QR Group Explains the Impact of the Mais Médicos Program in Brazil

QR Group explains how the Mais Médicos Program increases vacancies for professionals with CRM Brazil.

Understand how the Mais Médicos program is strengthening healthcare in Brazil, with 95% of vacancies filled by professionals trained in the country and the growing participation of quota holders The Mais Médicos program, which has reached its 38th cycle, continues to expand access to healthcare in Brazil, filling 95% of new vacancies with professionals trained […]

Challenges for companies and inspectors in interpreting the requirements of legislation and international standards of Health Surveillance

QR Group conducts training with Health Surveillance in Nova Lima, MG and explains that there are challenges in interpreting the requirements.

One of the biggest challenges for companies that manufacture or import/distribute health products is understanding and/or interpreting regulatory requirements, whether they are resolutions/legislation or international standards of the Health Surveillance Agency. The applicability of certain requirements in certain segments must be carefully assessed by both companies and authorities, which makes the inspection process by health […]

Registering Medical Products in Brazil – What do you need to know?

QR Group explains how to Registering Medical Products in Brazil and details how ANVISA segments categories and classes.

Registering medical products in Brazil goes through ANVISA – the National Health Surveillance Agency – which is the agency responsible for approving the marketing of any product related to human health in Brazil. The agency divides products into categories, such as health products, cosmetics, cleaning products, medicines, food, cannabis products and tobacco. The first step […]

Why is Good Manufacturing Practices Training Essential in Brazil?

QR Group offers good manufacturing practices training solutions to ensure ANVISA compliance and quality in Brazil.

QR Group Explains How Training Can Be a Competitive Advantage in the Healthcare Market In Brazil, where the healthcare sector is constantly evolving, companies that invest in good manufacturing practices stand out for the quality and safety of their products. QR Group, a specialist in regulatory consulting and product registration with ANVISA, reinforces the importance […]